SKIPPEROpen system:Venous Reservoir/Cardiotomy,Oxygenator unit integrated with heat exchanger.
Code:EU5007 Egypt - English - EDA (Egyptian Drug Authority)

skipperopen system:venous reservoir/cardiotomy,oxygenator unit integrated with heat exchanger. code:eu5007

ايه اتش ام ميديكال للاستيراد و التصدير و المستلزمات الطبية الخفيفة -

CARDIAMED PROSTHETIC HEART VALVE Egypt - English - EDA (Egyptian Drug Authority)

cardiamed prosthetic heart valve

شركة ايه اتش ام ميديكال للاستيراد و التصدير و المستلزمات الطبية الخفيفة -

Seroxat Tab 20 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

seroxat tab 20 mg

مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - paroxetine 20 mg - 20 mg

DESFERAL 0.5 G. Israel - English - Ministry of Health

desferal 0.5 g.

novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

DESFERAL 0.5 G. Israel - English - Ministry of Health

desferal 0.5 g.

novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

DESFERAL 0.5 G. Israel - English - Ministry of Health

desferal 0.5 g.

novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

Entresto 25.7 mg, 24.3 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

entresto 25.7 mg, 24.3 mg

شركة مستودع الأدوية الأردني - the jordan drugstore co - valsartan 25.7 mg, sacubitril 24.3 mg - 25.7 mg, 24.3 mg

Entresto 100mg 51.4 mg, 48.6 Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

entresto 100mg 51.4 mg, 48.6

شركة مستودع الأدوية الأردني - the jordan drugstore co - valsartan 51.4 mg, sacubitril 48.6 - 51.4 mg, 48.6